Global Cardiac Biomarkers Market Overview:
As per the latest report by IMARC Group, titled “Cardiac Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, offers a comprehensive analysis of the industry, which comprises insights on the Cardiac Biomarkers Market Report. The report also includes competitor and regional analysis, and contemporary advancements in the market. The global cardiac biomarkers market reached a value of US$ 9.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 14.9 Billion by 2027, exhibiting at a CAGR of 8.5% during 2022-2027. Cardiac biomarkers are intracellular macromolecules released from a heart muscle when it is damaged as a result of myocardial infarction (MI). The measurement and testing of these markers aid in diagnosing multiple heart conditions, including cardiac ischemia and acute coronary syndrome (ACS). Consequently, they are extensively used in laboratory and point of care testing.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Sample Report:https://www.imarcgroup.com/cardiac-biomarkers-market/requestsample
Global Cardiac Biomarkers Market Trends:
The global market is majority driven by the rising number of patients suffering from ACS. Cardiac biomarkers help in the early diagnosis of ACS and other cardiac conditions, thereby providing a thrust to the market growth. In addition, the rising awareness among patients regarding the importance of early diagnosis and continual improvements in healthcare facilities across the globe have created a positive outlook for the market. Other factors, including increasing investments in research and development (R&D) activities, high accuracy offered by cardiac biomarkers and the rising healthcare expenditures, are providing an impetus to the market growth.
Global Cardiac Biomarkers Market 2022-2027 Analysis and Segmentation:
Competitive Landscape with Key Players:
- Abbott Laboratories
- Alere Inc.
- Beckman Coulter
- Becton
- Dickinson And Co.
- Biomerieux
- Bio-Rad Laboratories
- Randox Laboratories
- Roche Diagnostics Corporation
- Siemens Healthcare
- Thermo Fisher Scientific.
Breakup by Type:
- Troponins (T and I)
- Myocardial Muscle Creatine Kinase (CK-MB)
- Myoglobin
- Brain Natriuretic Peptide (BNPs) or NT-proBNP
- Ischemia Modified Albumin (IMA)
- Others
By Location of Testing:
- Laboratory Testing
- Point of Care Testing
Breakup by Application:
- Myocardial Infarction
- Congestive Heart Failure
- Acute Coronary Syndrome
- Atherosclerosis
- Others
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (Germany, France, United Kingdom, Italy, Spain, Others)
- Europe (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Read More: https://eyesicon.com/white-box-server-market-report-2022-2027-and-forecast/